AI in clinical trial adherence and retention: is it a Pandora's box?
Can AI potentially help participants stick to the study all the way to the end, while also pointing to clinical trial sponsor blind spots?
Stay updated with breaking news from Eric Perakslis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Can AI potentially help participants stick to the study all the way to the end, while also pointing to clinical trial sponsor blind spots?
The Crisis Text Line’s AI-driven chat service has gathered troves of data from its conversations with people suffering life’s toughest situations. What happens next raises complex ethical questions.
While healthcare professionals have been quick to embrace new technologies, they've also been slow to understand cyber threats.
Andrey SuslovGetty Images Almost all of us can report those eerie “coincidences”—targeted ads on social media for, say, open-toed wedge sandals when you’d swear you were just daydreaming about a vacation someplace warm. Something in your search history or shopping patterns told the Facebook gods that you’d click on an image of shoes. It’s weird, you may think, but no big deal. Companies are increasingly discovering, however, that there’s gold to be mined in a topic much closer to home and with more potential to harm you than footwear preferences: your health. Amassing persona...